Global Chronic Idiopathic Myelofibrosis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 109 pages | ID: GD4CB2FA746GEN
GlobalInfoResearch

Abstracts

Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively affect on the development of white blood cells (WBCs), red blood cells (RBCs) and platelets. The condition of idiopathic myelofibrosis may ultimately lead to the risk of acute myelogenous leukemia. Risk of idiopathic myelofibrosis is more in geriatric population as compared to children and adult population. Patients may develop symptoms such as weakness, weight loss, night sweats, hypertension and others. Blood chemistry tests, bone marrow aspiration, molecular testing and biopsy are useful diagnostic tools to diagnose and detect chronic idiopathic myelofibrosis. Patients with idiopathic myelofibrosis are advised to take drugs like hydroxyurea, interferon alfa, androgens, prednisone and others in order to treat this disorder. In addition, stem cell transplant and splenectomy is performed by physicians in severe cases of chronic idiopathic myelofibrosis.

SCOPE OF THE REPORT:

This report studies the Chronic Idiopathic Myelofibrosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chronic Idiopathic Myelofibrosis market by product type and applications/end industries.
The market of chronic idiopathic myelofibrosis is majorly driven by consistent efforts of key players to develop new and effective therapeutics. In addition, strategic collaboration and acquisition adopted by key players will further act as a driving factor for this market.
The global Chronic Idiopathic Myelofibrosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chronic Idiopathic Myelofibrosis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• S-BIO
• YM BioSciences
• Sanofi
• Onyx Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Chemotherapy
• Biological Therapy
• Others

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Research Institutes

Contents

1 CHRONIC IDIOPATHIC MYELOFIBROSIS MARKET OVERVIEW

1.1 Product Overview and Scope of Chronic Idiopathic Myelofibrosis
1.2 Classification of Chronic Idiopathic Myelofibrosis by Types
  1.2.1 Global Chronic Idiopathic Myelofibrosis Revenue Comparison by Types (2017-2023)
  1.2.2 Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Types in 2017
  1.2.3 Chemotherapy
  1.2.4 Biological Therapy
  1.2.5 Others
1.3 Global Chronic Idiopathic Myelofibrosis Market by Application
  1.3.1 Global Chronic Idiopathic Myelofibrosis Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Research Institutes
1.4 Global Chronic Idiopathic Myelofibrosis Market by Regions
  1.4.1 Global Chronic Idiopathic Myelofibrosis Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Chronic Idiopathic Myelofibrosis Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Chronic Idiopathic Myelofibrosis Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Idiopathic Myelofibrosis Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Chronic Idiopathic Myelofibrosis Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Idiopathic Myelofibrosis Status and Prospect (2013-2023)
1.5 Global Market Size of Chronic Idiopathic Myelofibrosis (2013-2023)

2 MANUFACTURERS PROFILES

2.1 S-BIO
  2.1.1 Business Overview
  2.1.2 Chronic Idiopathic Myelofibrosis Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 S-BIO Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.2 YM BioSciences
  2.2.1 Business Overview
  2.2.2 Chronic Idiopathic Myelofibrosis Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 YM BioSciences Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
  2.3.1 Business Overview
  2.3.2 Chronic Idiopathic Myelofibrosis Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Sanofi Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Onyx Pharmaceuticals
  2.4.1 Business Overview
  2.4.2 Chronic Idiopathic Myelofibrosis Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CHRONIC IDIOPATHIC MYELOFIBROSIS MARKET COMPETITION, BY PLAYERS

3.1 Global Chronic Idiopathic Myelofibrosis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Chronic Idiopathic Myelofibrosis Players Market Share
  3.2.2 Top 10 Chronic Idiopathic Myelofibrosis Players Market Share
3.3 Market Competition Trend

4 GLOBAL CHRONIC IDIOPATHIC MYELOFIBROSIS MARKET SIZE BY REGIONS

4.1 Global Chronic Idiopathic Myelofibrosis Revenue and Market Share by Regions
4.2 North America Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
4.3 Europe Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
4.5 South America Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CHRONIC IDIOPATHIC MYELOFIBROSIS REVENUE BY COUNTRIES

5.1 North America Chronic Idiopathic Myelofibrosis Revenue by Countries (2013-2018)
5.2 USA Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
5.3 Canada Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
5.4 Mexico Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)

6 EUROPE CHRONIC IDIOPATHIC MYELOFIBROSIS REVENUE BY COUNTRIES

6.1 Europe Chronic Idiopathic Myelofibrosis Revenue by Countries (2013-2018)
6.2 Germany Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
6.3 UK Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
6.4 France Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
6.5 Russia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
6.6 Italy Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC CHRONIC IDIOPATHIC MYELOFIBROSIS REVENUE BY COUNTRIES

7.1 Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue by Countries (2013-2018)
7.2 China Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
7.3 Japan Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
7.4 Korea Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
7.5 India Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA CHRONIC IDIOPATHIC MYELOFIBROSIS REVENUE BY COUNTRIES

8.1 South America Chronic Idiopathic Myelofibrosis Revenue by Countries (2013-2018)
8.2 Brazil Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
8.3 Argentina Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
8.4 Colombia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE CHRONIC IDIOPATHIC MYELOFIBROSIS BY COUNTRIES

9.1 Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
9.3 UAE Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
9.4 Egypt Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
9.6 South Africa Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)

10 GLOBAL CHRONIC IDIOPATHIC MYELOFIBROSIS MARKET SEGMENT BY TYPE

10.1 Global Chronic Idiopathic Myelofibrosis Revenue and Market Share by Type (2013-2018)
10.2 Global Chronic Idiopathic Myelofibrosis Market Forecast by Type (2018-2023)
10.3 Chemotherapy Revenue Growth Rate (2013-2023)
10.4 Biological Therapy Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)

11 GLOBAL CHRONIC IDIOPATHIC MYELOFIBROSIS MARKET SEGMENT BY APPLICATION

11.1 Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Application (2013-2018)
11.2 Chronic Idiopathic Myelofibrosis Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Research Institutes Revenue Growth (2013-2018)

12 GLOBAL CHRONIC IDIOPATHIC MYELOFIBROSIS MARKET SIZE FORECAST (2018-2023)

12.1 Global Chronic Idiopathic Myelofibrosis Market Size Forecast (2018-2023)
12.2 Global Chronic Idiopathic Myelofibrosis Market Forecast by Regions (2018-2023)
12.3 North America Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
12.4 Europe Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
12.6 South America Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Chronic Idiopathic Myelofibrosis Picture
Table Product Specifications of Chronic Idiopathic Myelofibrosis
Table Global Chronic Idiopathic Myelofibrosis and Revenue (Million USD) Market Split by Product Type
Figure Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Types in 2017
Figure Chemotherapy Picture
Figure Biological Therapy Picture
Figure Others Picture
Table Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) by Application (2013-2023)
Figure Chronic Idiopathic Myelofibrosis Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Institutes Picture
Table Global Market Chronic Idiopathic Myelofibrosis Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate (2013-2023)
Table S-BIO Basic Information, Manufacturing Base and Competitors
Table S-BIO Chronic Idiopathic Myelofibrosis Type and Applications
Table S-BIO Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)
Table YM BioSciences Basic Information, Manufacturing Base and Competitors
Table YM BioSciences Chronic Idiopathic Myelofibrosis Type and Applications
Table YM BioSciences Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Chronic Idiopathic Myelofibrosis Type and Applications
Table Sanofi Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)
Table Onyx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Type and Applications
Table Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Revenue, Gross Margin and Market Share (2016-2017)
Table Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) by Players (2013-2018)
Table Global Chronic Idiopathic Myelofibrosis Revenue Share by Players (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Share by Players in 2016
Figure Global Chronic Idiopathic Myelofibrosis Revenue Share by Players in 2017
Figure Global Top 5 Players Chronic Idiopathic Myelofibrosis Revenue Market Share in 2017
Figure Global Top 10 Players Chronic Idiopathic Myelofibrosis Revenue Market Share in 2017
Figure Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) by Regions (2013-2018)
Table Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Regions (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Regions (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Regions in 2017
Figure North America Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Europe Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure South America Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Table North America Chronic Idiopathic Myelofibrosis Revenue by Countries (2013-2018)
Table North America Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure North America Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure North America Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries in 2017
Figure USA Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Canada Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Mexico Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Table Europe Chronic Idiopathic Myelofibrosis Revenue (Million USD) by Countries (2013-2018)
Figure Europe Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure Europe Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries in 2017
Figure Germany Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure UK Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure France Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Russia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Italy Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries in 2017
Figure China Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Japan Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Korea Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure India Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Table South America Chronic Idiopathic Myelofibrosis Revenue by Countries (2013-2018)
Table South America Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure South America Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure South America Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries in 2017
Figure Brazil Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Argentina Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Colombia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure UAE Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Egypt Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure Nigeria Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Figure South Africa Chronic Idiopathic Myelofibrosis Revenue and Growth Rate (2013-2018)
Table Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) by Type (2013-2018)
Table Global Chronic Idiopathic Myelofibrosis Revenue Share by Type (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Share by Type (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Share by Type in 2017
Table Global Chronic Idiopathic Myelofibrosis Revenue Forecast by Type (2018-2023)
Figure Global Chronic Idiopathic Myelofibrosis Market Share Forecast by Type (2018-2023)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Figure Global Biological Therapy Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Chronic Idiopathic Myelofibrosis Revenue by Application (2013-2018)
Table Global Chronic Idiopathic Myelofibrosis Revenue Share by Application (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Share by Application (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Share by Application in 2017
Table Global Chronic Idiopathic Myelofibrosis Revenue Forecast by Application (2018-2023)
Figure Global Chronic Idiopathic Myelofibrosis Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Research Institutes Revenue Growth Rate (2013-2018)
Figure Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Chronic Idiopathic Myelofibrosis Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Chronic Idiopathic Myelofibrosis Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
Figure Europe Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
Figure South America Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Chronic Idiopathic Myelofibrosis Revenue Market Forecast (2018-2023)